Legence Corp (LGN) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong growth potential supported by positive analyst ratings, recent acquisition activity, and robust revenue growth. Despite minor technical weaknesses and a slight pre-market dip, the company's fundamentals and positive sentiment outweigh short-term fluctuations.
The MACD is negative and expanding (-0.648), indicating bearish momentum. RSI is neutral at 37.234, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong trend. Key support is at $48.503, and resistance is at $52.758. The stock is trading near support levels, which could present a buying opportunity.

Engle Capital Management recently acquired 559,000 shares worth $24.06 million, signaling institutional confidence.
Record Q3 revenue of $708 million, up 26% YoY, and adjusted EBITDA growth of 39%.
Positive analyst sentiment with multiple price target upgrades and Buy ratings.
AI infrastructure momentum and the Bowers Group acquisition are expected to drive future growth.
Net income dropped by 46.81% YoY in Q3 2025, reflecting profitability challenges.
Pre-market price is down 0.87%, indicating short-term bearish sentiment.
Technical indicators show bearish momentum with no immediate bullish signals.
In Q3 2025, revenue increased by 26.25% YoY to $708 million, and gross margin improved by 5.42% to 17.5%. However, net income declined by 46.81% YoY to -$576,000, and EPS remained negative at -0.01. The company is demonstrating strong revenue growth but faces profitability challenges.
Analysts have a positive outlook on Legence. Goldman Sachs raised its price target to $52 with a Buy rating, Stifel raised its target to $58 with a Buy rating, and Tigress Financial raised its target to $60, citing AI infrastructure momentum and acquisition benefits. Barclays raised its target to $45 but maintained an Equal Weight rating, reflecting a more cautious stance.